Pramocaine: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Pramocaine Pramoxine.svg|Pramocaine Pramoxine | |||
File:Pramocaine_synthesis.svg|Pramocaine synthesis | |||
</gallery> | |||
Revision as of 01:45, 17 February 2025
Pramocaine (also known as proparacaine) is a local anesthetic of the amino ester group that is primarily used in topical ointic and ophthalmic preparations. It is also used in some surgical procedures.
History
Pramocaine was first synthesized in the mid-20th century and has been in use as a local anesthetic since then. It is a derivative of para-aminobenzoic acid (PABA).
Pharmacology
Pramocaine works by inhibiting sodium ion channels on the nerve cell membrane, preventing the propagation of action potentials and thus blocking the transmission of pain signals. It is a relatively weak anesthetic and has a short duration of action.
Uses
Pramocaine is primarily used in topical ointic and ophthalmic preparations. It is also used in some surgical procedures, particularly in ophthalmology, for local anesthesia.
Side Effects
Possible side effects of pramocaine include allergic reactions, skin irritation, and systemic toxicity if absorbed in large amounts.
Contraindications
Pramocaine is contraindicated in patients with a known hypersensitivity to it or to any other ester-type local anesthetic. It should also be used with caution in patients with impaired cardiovascular function.
See Also
References
<references />


